CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers
July 17, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
[Latest] Global Bispecific Antibodies Market Size/Share Worth USD 53.8 Billion by 2033 at a 24.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 04, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, April 04, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bispecific Antibodies Market Size, Trends and Insights By Application (Cancer...
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
January 29, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
January 17, 2024 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the...
CARGO Therapeutics Announces Pricing of Initial Public Offering
November 09, 2023 20:07 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Announce Pricing of IPO
T-Cell Therapy Market to Reach US$ 76.6 Billion by 2033, As Per Transparency Market Research, Inc.
February 06, 2023 13:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. –The global T-cell therapy market is estimated to grow at a CAGR of 27.9% by the end of 2033,...
The cell therapy manufacturing market is anticipated to grow at an annualized rate of over 12%, claims Roots Analysis
November 22, 2022 09:00 ET
|
Roots Analysis
London, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings. Owing to the...
Global T-Cell Lymphoma Market Size to grow USD 3390.6 Million by 2030 | CAGR of 8.50%
November 08, 2022 13:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Nov. 08, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global T-Cell lymphoma market size to grow from USD...
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
June 15, 2022 08:00 ET
|
Hyris
LONDON, June 15, 2022 (GLOBE NEWSWIRE) -- With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health...
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
October 14, 2021 07:50 ET
|
Hyris
LONDON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- After almost two years of fight against COVID-19, governments, NGOs, and corporations are now focusing on strategies and solutions to boost population...